1. Home
  2. GLMD

as of 12-04-2025 3:35pm EST

$1.14
+$0.07
+6.54%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.

Chart Type:
Time Range:
Founded: 2000 Country:
Israel
Israel
Employees: N/A City: N/A
Market Cap: 6.6M IPO Year: 2014
Target Price: N/A AVG Volume (30 days): 6.3M
Analyst Decision: Hold Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -2.71 EPS Growth: N/A
52 Week Low/High: $0.74 - $3.61 Next Earning Date: 11-26-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

AI-Powered GLMD Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 76.71%
76.71%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: